Drug Candidate Software
-
based in USA
systems, advanced software for imaging and analytics, and remote cloud laboratories, we enable our pharmaceutical partners to more rapidly and efficiently discover new drug ...
-
Manufactured by Intelligencebased in GERMANY
that the process is inefficient and expensive: Pharma companies spend more than USD 1 Billion on developing a new drug, Drug candidates pass the clinical stage with a success rate as low as 10-15%, Of all US clinical studies, 86% fail to meet the recruitment targets on time, Dropout rates of clinical trials commonly range between 15-40%, Of ...
-
by InterXbased in USA
InterX Development Division focuses on bridging the risk gap in Drug Discovery from drug targets to novel candidates. The Development Division applies InterX’s proprietary computer-aided drug design platform, while developing collaborations with Research Centers, Pharma companies, Start-ups, Academia and Accelerators. Such ...
-
Manufactured by Vala Sciencesbased in USA
ValaDATE (Deep Analytics for Toxicity & Efficacy) AI is Vala’s development stage artificial intelligence platform that we believe will further automate and accelerate how we process the vast data produced by the Vala ...
-
Manufactured by Vala Sciencesbased in USA
CyteSeer reports the effect of each drug by collating data derived by proprietary speed-optimized algorithms, which segment and identify each cell, and then extract and parameterize the shape of every transient of every cell in the ...
-
by Elucidbased in USA
Introducing the first and only non-invasive image analysis software that employs CT angiography and patented computer algorithms, based on expert histologic examination of thousands of tissue samples, to objectively quantify the extent and stability of arterial plaque for tailored patient care. Accurate Clinical Insights Based on ...
-
based in USA
With our LIMS configurable technology and workflow templates, projects are completed in a fraction of the time and cost of standard LIMS ...
-
based in GERMANY
Reliable predictions to anticipate risks. Interlinked data to find new targets and design novel drugs. Real-world evidence to evaluate success. These capabilities eliminate the uncertainties that limit drug development but are data-intensive and experimentally inaccessible. Molecular Health Dataome Technology offers powerful solutions to ...
-
by Qlucore ABbased in SWEDEN
Qlucore's clinical diagnostics solutions for multi-omics companion and precision diagnostics include AI-powered, disease-specific machine learning based classifier models and are combined with patient-friendly visualizations in a an easy-to-use and cost-effective software solution which integrates with a wide range of data generating techniques and instruments. ...
-
based in USA
With our LIMS configurable technology and workflow templates, projects are completed in a fraction of the time and cost of standard LIMS ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you